©istock.com/Andrea Obzerova
Unsere KompetenzInterdisziplinäre Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patientinnen und Patienten.

Klinische FragestellungKnochenmarks-Dysfunktion, erblich; Differentialdiagnose

Zusammenfassung

Kurzinformation

Umfassendes differentialdiagnostisches panel für erbliche Knochenmarks-Dysfunktion mit 11 "core candidate"-Genen bzw. insgesamt >150 kuratierten Genen gemäß klinischer Verdachtsdiagnose

ID
KP4958
Anzahl Gene
77 Akkreditierte Untersuchung
Untersuchte Sequenzlänge
24,0 kb (Core-/Core-canditate-Gene)
168,4 kb (Erweitertes Panel: inkl. additional genes)
Analyse-Dauer
auf Anfrage
Material
  • EDTA-Blut (3-5 ml)
Diagnostische Hinweise

NGS +

[Sanger]

 

Genpanel

Ausgewählte Gene

NameExon-Länge (bp)OMIM-GReferenz-Seq.Erbgang
BRCA210257NM_000059.4AR
BRIP13750NM_032043.3AR
DKC11545NM_001363.5XLR
ELANE804NM_001972.4AD
GFI11269NM_005263.5AD
HAX1840NM_006118.4AR
PALB23561NM_024675.4AR
RPL35A333NM_000996.4AD
RPS19438NM_001022.4AD
RPS24393NM_033022.4AD
SBDS753NM_016038.4AR
ATM9171NM_000051.4AR
BRCA15592NM_007294.4AR
CBL2721NM_005188.4AD
CEBPA1077NM_004364.5AD
CSF3R2511NM_000760.4AD, AR
CTC13654NM_025099.6AR
CXCR41059NM_003467.3AD
DNAJC212049NM_001012339.3AR
EFL13382NM_001040610.3AR
ERCC42751NM_005236.3AR
ERCC6L22106NM_001010895.4AR
FANCA4368NM_000135.4AR
FANCB2580NM_001018113.3XL
FANCC1677NM_000136.3AR
FANCE1611NM_021922.3AR
FANCF1125NM_022725.4AR
FANCG1869NM_004629.2AR
FANCI3987NM_001113378.2AR
FANCL1128NM_018062.4AR
FANCM6147NM_020937.4AR
FLT32982NM_004119.3AD, SMu
G6PC31041NM_138387.4AR
GATA11242NM_002049.4XLR
GATA21443NM_032638.5AD
GLRX5474NM_016417.3AR
HBA1429NM_000558.5AD, AR
HBA2429NM_000517.6AD, AR
HBB444NM_000518.5AD, AR
MLH12271NM_000249.4AR
MPL1908NM_005373.3AR
MSH22805NM_000251.3AR
MSH64083NM_000179.3AR
NBN2265NM_002485.5AR, Sus
NF18457NM_001042492.3AD
NHP2273NM_001034833.2AR
NOP10195NM_018648.4AR
PARN1920NM_002582.4AD, AR
PMS22589NM_000535.7AR
PRF11668NM_001083116.3AR
PTPN111782NM_002834.5AD
RAD51C1131NM_058216.3AR
RMRP300NR_003051.3AR
RPL11537NM_000975.5AD
RPL5894NM_000969.5AD
RPS17408NM_001021.6AD
RPS26348NM_001029.5AD
RPS29204NM_001030001.4AD
RPS7585NM_001011.4AD
RTEL13732NM_032957.5AD, AR
SAMD94770NM_001193307.2AD
SAMD9L4756NM_152703.5AD
SLC2A11479
  • Keine OMIM-Gs verknüpft
NM_006516.4AD
SLC4A12736NM_000342.4AD
SLX45505NM_032444.4AR
STN11221NM_024928.5AD
TAFAZZIN879NM_000116.5XLR
TCN21284NM_000355.4AR
TERT3399NM_198253.3AR, AD
TINF21356NM_001099274.3AD
TP531182NM_000546.6AD
VPS451617NM_007259.5AR
WAS1509NM_000377.3XLR
WIPF11512NM_001077269.1AR
WRAP531647NM_001143990.2AR
XK1335NM_021083.4XL
XRCC2843NM_005431.2AR

Infos zur Erkrankung

Klinischer Kommentar

Triphasisch, mit 2-5 Jahren (am häufigsten vererbt), zwischen 20-25 Jahren, nach 65 Jahren (erworbene Ursachen); vererbt 10%-15%, 30% pädiatrisch -> 65/1 000 000 Lebendgeburten/Jahr

 

Synonyme
  • Alias: Bone marrow failure syndromes, inherited
  • Allelic: AIDS, rapid progression to (IFNG)
  • Allelic: Breast-ovarian cancer, familial, 1 (BRCA1)
  • Allelic: Cartilage-hair hypoplasia (RMRP)
  • Allelic: Dyskeratosis congenita, AD 2 (TERT)
  • Allelic: Dyskeratosis congenita, AD 4 (RTEL1)
  • Allelic: Dyskeratosis congenita, AR 4 (TERT)
  • Allelic: Dyskeratosis congenita, AR 5 (RTEL1)
  • Allelic: Emberger syndrome (GATA2)
  • Allelic: Hepatitis C virus, response to therapy of (IFNG)
  • Allelic: Immunodeficiency 21 (GATA2)
  • Allelic: Immunodeficiency 69, mycobacteriosis (IFNG)
  • Allelic: Juvenile myelomonocytic leukemia (CBL)
  • Allelic: Leukemia, acute lymphoblastic (NBN)
  • Allelic: Leukemia, acute myeloid (TERT)
  • Allelic: Leukemia, acute myeloid, susceptibility to (GATA2)
  • Allelic: Leukemia, megakaryoblastic, with/-out Down syndrome, somatic (GATA1)
  • Allelic: Melanoma, cutaneous malignant, 9 (TERT)
  • Allelic: Metaphyseal dysplasia without hypotrichosis (RMRP)
  • Allelic: Monosomy 7 myelodysplasia + leukemia syndrome 2 (SAMD9)
  • Allelic: Myocardial infarction, susceptibility to (GCLC)
  • Allelic: Neural tube defects, folate-sensitive, susceptibility to (MTR)
  • Allelic: Neural tube defects, folate-sensitive, susceptibility to (MTRR)
  • Allelic: Neurodevelopmental disorder with visual defects + brain anomalies (HK1)
  • Allelic: Neuropathy, hereditary motor + sensory, Russe type (HK1)
  • Allelic: Nijmegen breakage syndrome (NBN)
  • Allelic: Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (CBL)
  • Allelic: Pancreatic cancer, susceptibility to, 4 (BRCA1)
  • Allelic: Proteinuria, chronic benign (CUBN)
  • Allelic: Resistance to malaria due to G6PD deficiency (G6PD)
  • Allelic: Retinitis pigmentosa 79 (HK1)
  • Allelic: TSC2 angiomyolipomas, renal, modifier of (IFNG)
  • Allelic: Thrombocythemia 2 (MPL)
  • Allelic: Thrombocytopenia with beta-thalassemia, XL (GATA1)
  • Allelic: Thrombocytopenia, XL (WAS)
  • Allelic: Thrombocytopenia, XL, intermittent (WAS)
  • Allelic: Thrombocytopenia, XL, with /-out dyserythropoietic anemia (GATA1)
  • Allelic: Thrombocytopenia, congenital amegakaryocytic (MPL)
  • Allelic: Tuberculosis, protection against (IFNG)
  • Allelic: Tumoral calcinosis, familial, normophosphatemic (SAMD9)
  • Allelic: Wilms tumor (BRCA2)
  • Allelic: Wiskott-Aldrich syndrome (WAS)
  • Allelic: XFE progeroid syndrome (ERCC4)
  • Allelic: Xeroderma pigmentosum, group F (ERCC4)
  • Allelic: Xeroderma pigmentosum, type F/Cockayne syndrome (ERCC4)
  • Acute myeloid leukaemia [panelapp] (NPM1)
  • Adenosine triphosphate, elevated, of erythrocytes (PKLR)
  • Allelic: Cowden syndrome 7 (SEC23B
  • Allelic: Distal renal tubular acidosis 1 (SLC4A1)
  • Allelic: Dystonia 9 (SLC2A1)
  • Allelic: Epilepsy, idiopathic generalized, susceptibility to, 12 (SLC2A1)
  • Allelic: Lymphatic malformation 6 (PIEZO1)
  • Allelic: Stomatin-deficient cryohydrocytosis with neurologic defects (SLC2A1)
  • Alpha-thalassemia/mental retardation syndrome (ATRX)
  • Anauxetic dysplasia 1 (RMRP)
  • Anemia, XL, with/-out neutropenia and/or platelet abnormalities (GATA1)
  • Anemia, hemolytic, Rh-null, regulator type (RHAG)
  • Anemia, hemolytic, due to UMPH1 deficiency (NT5C3A)
  • Anemia, hypochromic microcytic, with iron overload 1 (SLC11A2)
  • Anemia, neonatal hemolytic, fatal or near-fatal (SPTB)
  • Anemia, sideroblastic, 1 (ALAS2)
  • Anemia, sideroblastic, 2, pyridoxine-refractory (SLC25A38)
  • Anemia, sideroblastic, with ataxia (ABCB7)
  • Aplastic anemia (IFNG; NBN, PRF1, SBDS)
  • Aplastic anemia, susceptibility to (SBDS)
  • Ataxia-pancytopenia syndrome (SAMD9L)
  • Atransferrinemia (TF)
  • Bone marrow failure syndrome 2 (ERCC6L2)
  • Bone marrow failure syndrome 3 (DNAJC21)
  • Congenital dyserythropoietic anemia type III [panelapp] (KIF23)
  • Cryohydrocytosis (SLC4A1)
  • Dehydrated hereditary stomatocytosis with/-out pseudohyperkalemia +/- perinatal edema (PIEZO1)
  • Diamond-Blackfan anemia 1 (RPS19)
  • Diamond-Blackfan anemia 10 (RPS26)
  • Diamond-Blackfan anemia 13 (RPS29)
  • Diamond-Blackfan anemia 4 (RPS17)
  • Diamond-Blackfan anemia 5 (RPL35A)
  • Diamond-Blackfan anemia 6 (RPL5)
  • Diamond-Blackfan anemia 7 (RPL11)
  • Diamond-Blackfan anemia 8 (RPS7)
  • Diamond-Blackfan anemia 9 (RPS10)
  • Diamond-blackfan anemia 3 (RPS24)
  • Distal renal tubular acidosis 4 with hemolytic anemia (SLC4A1)
  • Dyserythropoietic anemia, congenital, type II (SEC23B)
  • Dyserythropoietic anemia, congenital, type Ia (CDAN1)
  • Dyserythropoietic anemia, congenital, type Ib (C15orf41 syn. CDIN1)
  • Dyskeratosis congenita, AD 3 (TINF2)
  • Dyskeratosis congenita, AR 2 (NHP2)
  • Dyskeratosis congenita, AR 3 (WRAP53)
  • Dyskeratosis congenita, XL (DKC1)
  • Elliptocytosis-1 (EPB41)
  • Elliptocytosis-2 (SPTA1)
  • Elliptocytosis-3 (SPTB)
  • Exocrine pancreatic insufficiency, dyserythropoietic anemia + calvarial hyperostosis (COX4I2)
  • Familial MDS; Myelodysplastic syndromes (CEBPA)
  • Fanconi anemia, complementation group A (FANCA)
  • Fanconi anemia, complementation group B (FANCB)
  • Fanconi anemia, complementation group C (FANCC)
  • Fanconi anemia, complementation group D1 (BRCA2)
  • Fanconi anemia, complementation group D2 (FANCD2)
  • Fanconi anemia, complementation group E (FANCE)
  • Fanconi anemia, complementation group F (FANCF)
  • Fanconi anemia, complementation group G (FANCG)
  • Fanconi anemia, complementation group I (FANCI)
  • Fanconi anemia, complementation group J (BRIP)
  • Fanconi anemia, complementation group L (FANCL)
  • Fanconi anemia, complementation group N (PALB2)
  • Fanconi anemia, complementation group O (RAD51C)
  • Fanconi anemia, complementation group P (SLX4)
  • Fanconi anemia, complementation group Q (ERCC4)
  • Fanconi anemia, complementation group S (BRCA1)
  • Fanconi anemia, complementation group T (UBE2T)
  • GLUT1 deficiency syndrome 1, infantile onset, severe (SLC2A1)
  • GLUT1 deficiency syndrome 2, childhood onset (SLC2A1)
  • Glycogen storage disease VII (PFKM)
  • Glycogen storage disease XII (ALDOA)
  • Hemolytic anemia due to adenylate kinase deficiency (AK1)
  • Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (GCLC)
  • Hemolytic anemia due to hexokinase deficiency (HK1)
  • Hemolytic anemia due to triosephosphate isomerase deficiency (TPI1)
  • Hemolytic anemia, CD59-mediated, with/-out immune-mediated polyneuropathy (CD59)
  • Hemolytic anemia, G6PD deficient; favism (G6PD)
  • Homocystinuria-megaloblastic anemia, cbl E type (MTRR)
  • Homocystinuria-megaloblastic anemia, cblG complementation type (MTR)
  • Imerslund-Grasbeck syndrome 1 (CUBN)
  • Imerslund-Grasbeck syndrome 2 (AMN)
  • Immunodeficiency 52 (LAT)
  • Immunodeficiency, common variable, 13 (IKZF1)
  • Iron-refractory iron deficiency anemia (TMPRSS6)
  • MIRAGE s. [myelodyspl., infection, growth restr., adr. hypoplasia, genit. abn., enteropathy] (SAMD9)
  • Majeed syndrome (LPIN2)
  • Megaloblastic anemia due to dihydrofolate reductase deficiency (DHFR)
  • Mental retardation-hypotonic facies syndrome, XL (ATRX)
  • Monosomy 7 myelodysplasia and leukemia syndrome 1 (SAMD9L)
  • Myelodysplastic syndrome (MDS), Paediatric (CBL)
  • Myelodysplastic syndrome (MDS), Paediatric (FLT3)
  • Myelodysplastic syndrome, susceptibility to (GATA2)
  • Myelofibrosis with myeloid metaplasia, somatic (MPL)
  • Myelokathexis, isolated (CXCR4)
  • Myopathy, lactic acidosis + sideroblastic anemia 1 (PUS1)
  • Myopathy, lactic acidosis + sideroblastic anemia 2 (YARS2)
  • Neutropenia, cyclic (ELANE)
  • Neutropenia, nonimmune chronic idiopathic, of adults (GFI1)
  • Neutropenia, severe congenital 1, AD (ELANE)
  • Neutropenia, severe congenital 2, AD (GFI1)
  • Neutropenia, severe congenital 3, AR (HAX1)
  • Neutropenia, severe congenital 5, AR (VPS45)
  • Neutropenia, severe congenital 7, AR (CSF3R)
  • Neutropenia, severe congenital, XL (WAS)
  • Noonan syndrome-like disorder with/-out juvenile myelomonocytic leukemia (CBL)
  • Ovalocytosis, SA type (SLC4A1)
  • Overhydrated hereditary stomatocytosis (RHAG)
  • Porphyria, congenital erythropoietic (UROS)
  • Protoporphyria, erythropoietic, XL (ALAS2)
  • Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1 (TERT)
  • Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3 (RTEL)
  • Pyropoikilocytosis (SPTA1)
  • Pyruvate kinase deficiency (PKLR)
  • Radioulnar synostosis with amegakaryocytic thrombocytopenia 1 (HOXA11)
  • Revesz syndrome (TINF2)
  • Shwachman-Diamond syndrome (SBDS)
  • Shwachman-Diamond syndrome 2 (EFL1)
  • Sneddon syndrome (ADA2)
  • Spherocytosis, type 1 (ANK1)
  • Spherocytosis, type 2 (SPTB)
  • Spherocytosis, type 3 (SPTA1)
  • Spherocytosis, type 4 (SLC4A1)
  • Spherocytosis, type 5 (EPB42)
  • Syndromic intellectual disability; cytopenia [panelapp] (RAP1B)
  • Thiamine-responsive megaloblastic anemia syndrome (SLC19A2)
  • Thrombotic thrombocytopenic purpura, hereditary (ADAMTS13)
  • Transcobalamin II deficiency (TCN2)
  • Vasculitis, autoinflammation, immunodeficiency + hematologic defects syndrome (ADA2)
  • WHIM syndrome (CXCR4)
  • [Blood groups Diego, Froese, Swann, Waldner, Wright (SLC4A1)
  • [Malaria, resistance to (SLC4A1)
Erbgänge, Vererbungsmuster etc.
  • AD
  • AR
  • SMu
  • Sus
  • XL
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatik und klinische Interpretation

Kein Text hinterlegt